Original Paper

Surveillance of Antibacterial Resistance in Staphylococcus aureus Isolated in Kuwaiti Hospitals
E.E. Udo^a, N. Al-Sweih^a, R. Dhar^b, T.S. Dimitrov^b, E.M. Mokaddas^a, M. Johny^b, I.A. Al-Obaid^b, H.H. Gomaa^b, L.A. Mobasher^b, V.O. Rotimi^a, A. Al-Asar^b

Department of
^aMicrobiology, Faculty of Medicine, Kuwait University, and
^bMicrobiology Laboratories, Department of Laboratory Medicine, Ministry of Health, Kuwait

Address of Corresponding Author

Med Princ Pract 2008;17:71-75 (DOI: 10.1159/000109594)

  Key Words

• Methicillin-resistant Staphylococcus aureus
• Fusidic acid resistance
• Reduced susceptibility to vancomycin

  Abstract

Objective: To investigate the prevalence of antibiotic resistance among Staphylococcus aureus isolated in Kuwaiti hospitals. Materials and Methods:S. aureus were isolated and identified following standard microbiological methods. Antibacterial susceptibility test was performed by disk diffusion and the measurement of minimum inhibitory concentration with E-test strips. Results: A total of 1,846 S. aureus isolates were analyzed from 13 hospitals between 1 March and 30 October 2005. They were isolated from 1,765 (95.6%) inpatients and 81 (4.4%) outpatients. Methicillin resistance was detected in 588 (32.0%) of the isolates. The methicillin-resistant S. aureus (MRSA) consisted of 461 (78%) multiresistant and 127 (22%) nonmultiresistant isolates. The nonmultiresistant MRSA consisted of epidemic MRSA-15 and community-associated MRSA. The community-associated MRSA was detected in all hospitals with MRSA, indicating its establishment in Kuwaiti hospitals. The proportion of isolates resistant to gentamicin, kanamycin, erythromycin, tetracycline, ciprofloxacin, fusidic acid and trimethoprim was higher among MRSA than methicillin-susceptible S. aureus (MSSA) isolates. Twenty-four and 22% of MRSA and MSSA isolates, respectively, expressed reduced susceptibility to vancomycin (minimum inhibitory concentration = 3-4 mg/l). Conclusion: The study revealed the presence of methicillin resistance in 32% of S. aureus isolated in Kuwaiti hospitals and revealed an increase in the number of MRSA and MSSA with reduced susceptibility to vancomycin.

Copyright © 2007 S. Karger AG, Basel

  References

1.

Chambers HF: The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis 2001;7:178-182.

2.

Said-Salim B, Mathema B, Kreiswirth BN: Community acquired methicillin-resistant Staphylococcus aureus: an emerging problem. Infect Control Hosp Epidemiol 2003;24:451-455.

3.

Capitano B, Pharm D, Leshem OA, Nightingale CH, Nicolau DP: Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility. J Am Geriatr Soc 2003;51:10-16.

4.

Cosgrove SE, Qi Y, Kaye KS, Harbwrth S, Karchmer AW, Carmeli Y: The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-174.

5.

Udo EE, Pearman JW, Grubb WB: Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993;25:157-165.

6.

Maltezou HC, Giamarellou H: Community acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents 2006;27:87-96.

7.

Stemper M, Shukla, SK, Reed KD: Emergence and spread of community-associated methicillin-resistant Staphylococcus aureus in rural Wisconsin, 1989-1999. J Clin Microbiol 2004;42:5673-5680.

8.

Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D, Moore KA, Cheek JE: Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201-1205.

9.

Coombs GW, Nimmo GR, Bell JM, Huygens F, O'Brien FG, Malkowski MJ, Pearson JC, Stephens AJ, Giffard PM, Australian Group for Antimicrobial Resistance: Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol 2004;42:4735-4743.

10.

Udo EE, Al-Obaid IA, Jacob LE, Chugh TD: Molecular characterization of epidemic ciprofloxacin- and methicillin-resistant Staphylococcus aureus strains colonizing patients in an intensive care unit. J Clin Microbiol 1996;34:3242-3244.

11.

Udo EE, Al-Sweih N, Noronha B: Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait hospitals. Clin Microbiol Infect 2006;12:262-269.

12.

Udo EE, Al-Sweih N, Mohanakrishnan S, West PWJ: Antibacterial resistance and molecular typing of methicillin-resistant Staphylococcus aureus in a Kuwaiti general hospital. Med Princ Pract 2006;15:39-45.

13.

Zinn CS, Westh H, Rosdahl VT, SARISA Study Group: An international multicenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or States. Microb Drug Resist2004;10:160-168.

14.

Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; CLSI Approved Standard M100-S16. Wayne, Clinical and Laboratory Standards Institute, 2005.

15.

Dar JA, Thoker MA, Khan JA, Ali A, Khan MA, Rizwan M, Bhat KH, Dar MJ, Ahmed N, Ahmad S: Molecular epidemiology of clinical and carrier strains of methicillin-resistant Staphylococcus aureus (MRSA) in the hospital settings of north India. Ann Clin Microbiol Antimicrob 2006;5:22.

16.

Asghar AH, Momenah AM: Methicillin resistance among Staphylococcus aureus isolates from Saudi hospitals. Med Princ Pract 2006;15:52-55.

17.

Styers D, Sheehan DJ, Hogan P, Sahm DF: Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006;5:2.

18.

Jumaa PA, Neringer R: A survey of antimicrobial resistance in a tertiary referral hospital in the United Arab Emirates. J Chemother 2005;17:376-379.

19.

Austin TW, Austin MA, McAlear DE, Coleman BT, Osoba AO, Thaqafi AO, Lamfon MA: MRSA prevalence in a teaching hospital in Western Saudi Arabia. Saudi Med J 2003;24:1313-1316.

20.

Prasanna M, Thomas C: A profile of methicillin-resistant Staphylococcus aureus infection in the burn center of the Sultanate of Oman. Burns 1998;24:631-636.

21.

Bell JM, Turnidge JD, SENTRY APAC participants: High prevalence of oxacillin-resistant Staphylococcus aureus isolated from hospital patients in Asia-Pacific and South Africa: results from SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob Agents Chemother 2002;46:879-881.

22.

Richardson JF, Reith S: Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J Hosp Infect 1993;25:45-52.

23.

Pearman JW, Coombs GW, Grubb WB, O'Brien FA: British epidemic strain of methicillin-resistant Staphylococcus aureus (UK EMRSA-15) has become established in Australia. Med J Aust 2001;174:662.

24.

Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC: Methicillin-resistant Staphylococcus aureus clinical isolate with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-136.

25.

Song JH, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, Kiem S, Kim YS, Oh WS, Peck KR, Lee NY, Asian Network for Surveillance of Resistant Pathogens Study Group: Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2004;48:4926-4928.

26.

Kim HB, Lee YS, Kim BS, Cha JO, Kwon SU, Lee HJ, Suh JT, Rheem I, Kim JM, Shin BM, Kim MN, Lee K, Lee CS, Kim EC, Oh MD, Choe KW: Prevalence and clinical implications of Staphylococcus aureus with vancomycin MIC of 4 microg/ml in Korea. Microb Drug Resist 2006;12:33-38.

27.

Ward PB, Johnson PDR, Grabsch EA, Mayall BC, Grayson ML: Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust 2001;175:480-483.

  Author Contacts

Dr. Edet E. Udo
Department of Microbiology, Faculty of Medicine
Health Sciences Centre, Kuwait University
PO Box 24923, 13110 Safat (Kuwait)
Tel. +965 498 6773, Fax +965 533 2719, E-Mail edet@hsc.edu.kw

  Article Information

Received: November 27, 2006
Revised: March 6, 2007
Number of Print Pages : 5
Number of Figures : 0, Number of Tables : 3, Number of References : 27

  Publication Details

Medical Principles and Practice (International Journal of the Kuwait University Health Sciences Centre)

Vol. 17, No. 1, Year 2008 (Cover Date: December 2007)

Journal Editor: Owunwanne, A. (Kuwait)
ISSN: 1011-7571 (print), 1423-0151 (Online)

For additional information: http://www.karger.com/MPP

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.